SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-23-006724
Filing Date
2023-02-14
Accepted
2023-02-14 12:00:19
Documents
1
Group Members
ANCHORAGE ADVISORS MANAGEMENT, L.L.C.KEVIN M. ULRICH

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10047644_13ga.htm SC 13G/A 122610
  Complete submission text file 0001140361-23-006724.txt   124545
Mailing Address 610 BROADWAY 6TH FLOOR NEW YORK NY 10012
Business Address 610 BROADWAY 6TH FLOOR NEW YORK NY 10012 212-610-9077
Anchorage Capital Group, L.L.C. (Filed by) CIK: 0001300714 (see all company filings)

IRS No.: 200042271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92710 | Film No.: 23625170
SIC: 2836 Biological Products, (No Diagnostic Substances)